The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06015919
Recruitment Status : Completed
First Posted : August 29, 2023
Last Update Posted : August 29, 2023
Sponsor:
Collaborator:
faculty of physical therapy
Information provided by (Responsible Party):
Alaa Nabil Elsayed Mohamed, Cairo University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
A study of effect of dash diet and acupuncture on hypertension in postmenopausal women

Condition or disease Intervention/treatment Phase
Postmenopausal Disorder Behavioral: dash diet Device: Acupuncture Not Applicable

Detailed Description:

45 of post menopausal women divided into three groups A,B,C

  • Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.
  • Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.
  • Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 45 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Intervention Model Description: dash diet and acupuncture on post menopausal hypertention
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Dash Diet and Acupuncture on Hypertention in Postmenopausal Women
Actual Study Start Date : December 5, 2022
Actual Primary Completion Date : April 25, 2023
Actual Study Completion Date : August 20, 2023

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Acupuncture

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: effect of dash diet and acupuncture on hypertention in post menopausal women
  • Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.
  • Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.
  • Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.
 Behavioral: dash diet
  • Group (A): It will include 15 post-menopausal women who will be treated by DASH diet and anti-hypertensive drugs.
  • Group (B): It will include 15 post-menopausal women who will be treated by acupuncture and anti-hypertensive drugs.
  • Group (C): It will include 15 post-menopausal women who will be treated by DASH diet, acupuncture and anti-hypertensive drugs.

Device: Acupuncture
acupuncture


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. blood pressure [ Time Frame: 3 months ]
    it will be measured by sphygmomanometer pre and post treatment


Secondary Outcome Measures :
  1. sodium and potassium levels [ Time Frame: 3 months ]
    it will be measured by blood analysis pre and post treatment


Other Outcome Measures:
  1. assessment of quality of life [ Time Frame: 3 months ]
    it will be measured by sf 36 questionnaire pre and post treatment


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   post menopausal hypertensive women
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Their body mass index will be ranged from 25 -29.9 kg/m2
  • All patients will be medically stable when attending the study.
  • The DASH eating plan of 1800 kcal per day will be used in the study.

Exclusion Criteria:

  • Auditory and visual problems.
  • Chronic renal failure.
  • Myocardial infarction or arrythmias with heart failure.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06015919


Locations
Layout table for location information
Egypt
Alaa Nabil Elsayed Mohamed
Abu hammad, Elsharqia, Egypt, 44661
Sponsors and Collaborators
Cairo University
faculty of physical therapy
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Alaa Nabil Elsayed Mohamed, principal investigator, Cairo University
ClinicalTrials.gov Identifier: NCT06015919    
Other Study ID Numbers: P.T.REC/012/003872
First Posted: August 29, 2023    Key Record Dates
Last Update Posted: August 29, 2023
Last Verified: August 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No